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ABSTRACT 
 
Background: Of lung diseases, Hemoptysis is an alarming symptom. It is difficult for clinicians to choose how to deal 
with patients who had a single episode of hemoptysis, especially if the cause is unknown. Using multivariate analysis, 
investigations were done to see whether any factor in the initial episode could be a predictor of second episode. Aim: In 
this study, by using multivariate analysis, to check whether any clinical factor present during initial episode of hemoptysis 
are useful predictors of second episode of hemoptysis. Materials and Methods: 100 Patients with initial episode of 
hemoptysis, their medical records were reviewed. Patients who had undergone both chest CT and bronchoscopic 
examinations were selected in the study. Results: 100 patients were selected. From bronchial lavage fluid, active and 
inactive fluid were isolated in 17 (17%) cases. On further examination, diagnosis was not established in 27 (27%) cases. 
The predictors of hemoptysis were bacteria from bronchial lavage which has shown a 62 patients were negative for 
bacteria and 7 patients were positive for bacteria out of a total of 69 patients in initial episode and 21 patients showed 
negative to bacteria and 10 patients showed positive to bacteria out of a total of 31 patients in reccurent episode. All the 
demographic details of initial episode and recurrent cases are insignificant on comparision. Most of the cases of recurrent 
cases are positive for bacteria from bronchial lavage and ethiology is known. Regardless of the volume of the initial 
episode, the failure to determine the etiology of an initial episode of hemoptysis was associated with an increased risk of a 
massive second episode (P = 0.040).Conclusion: There is an increased possibility of a second episode of hemoptysis in 
patients with bacterial colonization of the respiratory tract or an initial episode of hemoptysis of unknown etiology. 
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Introduction  
 
Hemoptysis is the coughing up of blood or blood-stained 
mucus from the bronchi, larynx, trachea, or lungs. This 
can occur with lung cancer, infections such as 
tuberculosis, bronchitis, or pneumonia, and certain 
cardiovascular conditions[1].Hemoptysis is considered 
massive at 300 mL (11 imp fl oz; 10 US fl oz). In such 
cases, there are always severe injuries[2].The primary 
danger comes from choking, rather than blood loss. 
Conditions which commonly involve hemoptysis include 
bronchitis and pneumonia, lung cancers and tuberculosis. 
Other possible underlying causes include aspergilloma, 
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bronchiectasis, coccidioidomycosis, pulmonary embolism, 
pneumonic plague, and cystic fibrosis. Rarer causes 
include hereditary hemorrhagic telangiectasia (HHT or 
Rendu-Osler-Weber syndrome), Goodpasture's syndrome, 
and granulomatosis with polyangiitis. In children, 
hemoptysis is commonly caused by the presence of a 
foreign body in the airway[3].The condition can also 
result from over-anticoagulation from treatment by drugs 
such as warfarin. Blood-laced mucus from the sinus or 
nose area can sometimes be misidentified as symptomatic 
of hemoptysis (such secretions can be a sign of nasal or 
sinus cancer, but also a sinus infection). Extensive non-
respiratory injury can also cause one to cough up 
blood[4].Cardiac causes like congestive heart failure and 
mitral stenosis should be ruled out. The origin of blood 
can be identified by observing its color. Bright-red, foamy 
blood comes from the respiratory tract, whereas dark-red, 
coffee-colored blood comes from the gastrointestinal tract. 
Sometimes hemoptysis may be rust-colored. Of 
underlying diseases of lungs, hemoptysis is an alarming 
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symptom. The causes and variations in the reported 
prevalence is the main problem in treating hemoptysis, 
After the initial active bleeding has stopped with 
treatment, another problem arises which is second episode 
of hemoptysis[5].The second episode of hemoptysis may 
be severe , though the first episode was slight expulsion of 
blood sputum. Hence, it is difficult for clinicians to 
choose how to deal with patients who had a single episode 
of hemoptysis, especially if the cause is unknown. In this 
study, by using multivariate analysis, to check whether 
any clinical factor present during initial episode of 
hemoptysis are useful predictors of second episode of 
hemoptysis. 
 
Materials and Methods 
100 patients with initial episode of hemoptysis, their 
medical records were reviewed. All patients who had 
undergone both chest CT and bronchoscopic examinations 
were selected in the study. High resolution CT scans are 
routinely performed in this hospital if any abnormality is 
observed in the conventional CT scan. For culture of 
micro-organisms, bronchial lavage by polymerase chain 
reaction of mycobacterium and cytological examinations 
along with bronchoscopic examinations were performed. 
In relevant cases, endobronchial or transbronchial biopsy 
were performed. In cases of severe hemoptysis requiring 
embolotherapy, chest angiography was suggested. Patients 
upper airway bleeding were excluded from the study. The 
institutional review board approved this study and 
informed consent was taken from all the patients. On the 
basis of available clinical data, chest CT, and 
bronchoscopic findings, the cause of hemoptysis was 
determined. Infection is the bacterial isolation from the 
bronchial lavage fluid, accompanied by respiratory signs 
and symptoms, whereas colonization is a state in which 
host defenses limited the bacterial activity and hence such 
respiratory signs and symptoms were absent. Age, sex, 
smoking history, blood pressure, history of anticoagulant 
therapy, chest CT findings, type of bacteria isolated with 
bronchial lavage, etiology, time to recurrent hemoptysis, 
amounts of initial and recurrent hemoptysis, and treatment 
were collected from all the patients. The cases were 
divided into three groups namely Trivial (Blood streaked 
sputum), Moderate(<500 mL/24 hours) and massive 
(≥500 mL/24 hours). When appropriate, conservative 
treatment was given to all patients. Follow up was taken. 
Chi square test or Probability test was used to assess the 
relation between categorical variables. Mann-Whitney test 
was used to evaluate the difference in mean between 
groups. Statistical significance was indicated by P value 
less than 0.05. 
 
Results 
100 patients were selected. From bronchial lavage fluid, 
active and inactive fluid were isolated in 17 (17%) cases. 
On further examination, diagnosis was not established in 
27 (27%) cases.  
 
Table 1: Patients characteristics for prediction of recurrent hemoptysis 
 
Variable Total(n=100
) 
Initial 
Episode(69) 
Recurrent cases(31) P value 
Age (Years)<60/≥60 49/51 41/28 12/19 NS 
Gender Female/Male 22/78 20/49 6/25 NS 
Smoking Smoker/Non-smoker 60/40 45/24 17/14 NS 
Blood Pressure (mmHg) 
<160/≥160 
70/30 47/22 18/13 NS 
Anticoagulant therapy No/Yes 80/20 60/9 29/2 NS 
Chest CT abnormality  Yes/No 62/38 49/20 25/6 NS 
All the demographic details of initial episode and recurrent cases are insignificant on comparison 
 
Table 2: Patients characteristics for prediction of recurrent hemoptysis 
 
Variable Total(n=100) Initial Episode(69) Recurrent cases(31) P value 
Bacteria from bronchial lavage –ve/+ve 82/18 62/7 21/10 0.001 
Etiology  Known/Unknown 84/16 59/10 22/9 0.016 
Amount of initial bleeding 
Trivial/moderate or massive 
30/70 20/49 12/19 NS 
Initial treatment 
Conservative/Embolotherapy 
88/12 65/4 31/0 NS 
NS-Not significant 
Most of the cases of recurrent cases are positive for bacteria from bronchial lavage and etiology is known. 
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Table 3: Etiology of initial hemoptysis 
 
Known Total(n=100) Initial Episode(69) Recurrent 
cases(31) 
P value 
Bronchitis 25 20 7 NS 
Bronchiectasis 20 14 6 
Infection 16 10 5 
Others 16 14 3 
Unknown 23 11 10 
 
Table 4: Etiology of initial hemoptysis of infection 
 
Infection Total(n=16) Initial Episode(10) Recurrent cases(5) P value 
Pneumonia 4 4 0 NS 
Abscess 2 0 1 
Aspergilloma 4 2 3 
Tuberculosis 6 4 1 
 
Table 5: Etiology of initial hemoptysis for others 
 
Others Total(n=16) Initial Episode(14) Recurrent cases(3) P value 
Lung cancer 5 5 0 NS 
 Hemorrhagic diathesis 5 3 2 
Bronchial vascular abnormality 3 3 1 
Pulmonary sequestration 1 1 0 
Bronchial atresia 1 1 0 
Tracheal ulcer 1 1 0 
 
Discussion 
  
In our study, 100 patients were selected. From bronchial 
lavage fluid, active and inactive fluid were isolated in 17 
(17%) cases. On further examination, diagnosis was not 
established in 27 (27%) cases. Bacteria from bronchial 
lavage was the predictor of hemoptysis  which has shown 
a 62 patients were negative for bacteria and 7 patients 
were positive for bacteria out of a total of 69 patients in 
initial episode and 21 patients showed negative to bacteria 
and 10 patients showed positive to bacteria out of a total 
of 31 patients in reccurent episode. All the demographic 
details like age, gender, smoking, blood pressure, 
anticoagulant therapy, CT of chest abnormality, amount of 
initial bleeding and initial treatment embolotherapy of 
initial episode and recurrent cases are insignificant on 
comparision. Most of the cases of recurrent cases are 
positive for bacteria from bronchial lavage and ethiology 
is known. Regardless of the volume of the initial episode, 
the failure to determine the etiology of an initial episode 
of hemoptysis was associated with an increased risk of a 
massive second episode (P = 0.040), whereas in a study 
done by Nobuhiko Seki et al; odds ratio of 13.5, P = 
0.001 in the isolation of bacteria from bronchial lavage 
fluid was determined and odds ratio of 7.0, P = 0.014 in 
the failure to determine the cause of the initial episode of 
hemoptysis were significant independent predictors of a 
second episode of hemoptysis[6]. Even if colonization, 
representing host-bacterial equilibrium, had occurred, 
isolation of either Pseudomonas aeruginosa or 
Haemophilus influenzae increased the likelihood of a 
second episode of hemoptysis (P = 0.077) by subset 
analysis . Hence, regardless of the volume of the initial 
episode, the failure to determine the etiology of an initial 
episode of hemoptysis was associated with an increased 
risk of a massive second episode (P = 0.042).Adel Ayed 
et al[7]; conducted a study in which fifty-three patients 
were studied, 27 in group 1 and 26 in group 2. The mean 
age of the patients was 47.2 years (range, 29–70 years). 
Urgent examination with a combination of rigid and 
flexible fiberoptic bronchoscope localized the bleeding 
site in 45 patients (85%). Age>50 years, hypertension, 
hemoglobin on admission<10 g/dl, cause of hemoptysis, 
and a prior attack of hemoptysis were the predictors for 
the need of emergency surgery. The overall hospital 
mortality rate was 4% (2/53). Postoperative complications 
occurred in 13 patients (25%). Complications were more 
common in patients who received blood transfusion than 
non-transfused patients (9/23 and 4/30, respectively; 
P=0.03). Patients with tuberculosis as the cause of 
massive hemoptysis had more complications 5/8 in 
comparison to all other patients (P=0.02). The mean 
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follow-up was 4.5 years (range, 3–6 years) for all patients 
who survived. Hemoptysis recurred in four patients (8%) 
and all from group 1 (P=0.02).  Hirshberg B et 
al[8];observed that bronchiectasis (20%), lung cancer 
(19%), bronchitis (18%), and pneumonia (16%) accounted 
for most causes of hemoptysis. In contrast to older studies, 
active tuberculosis was a rare finding (1.4%). 
Bronchiectasis and bleeding diathesis were major causes 
of moderate to severe hemoptysis while bronchitis and 
lung cancer were commonly associated with milder 
degrees of bleeding. CT scan was the most sensitive 
diagnostic test when employed alone, with a positive yield 
of 67%. However, it failed to locate at least three cases of 
lung cancer. When combining a CT study together with a 
bronchoscopy, the positive yield increased to 93%. The 
mortality rate for patients with mild to moderate 
hemoptysis was low (2.5% and 6%, respectively), while 
patients with massive hemoptysis had high mortality rates 
(38%). Patients with lung cancer or bleeding diathesis had 
higher mortality rates compared with the rest of the 
cohort.   B R Lee et al[9]; found in their study that 
bronchiectasis (32.6%), active pulmonary tuberculosis 
(18.5%), fungus ball (10.8%), and lung cancer (5.9%) 
accounted for most causes of hemoptysis. Computed 
tomography scan was the most sensitive diagnostic test 
when employed alone, with positive yield of 93.2%. There 
were 161 cases of conservative treatment (72.9%), 42 
cases of bronchial artery embolization (BAE) (19.0%), 
and 18 cases of surgery (8.1%). Regarding the amount of 
hemoptysis, 70 cases, out of 221 cases, were mild 
(31.5%), 36 cases moderate (16.2%), and 115 cases 
massive hemoptysis (52.0%). Most of the patients were 
treated conservatively, but if there was more bleeding 
present, BAE or surgery was more commonly performed 
than the conservative treatment (p≤0.0001). In the 
multivariate model, severe hemoptysis and lung cancer 
were independently associated with short-term recurrence. 
BAE was independently associated with long-term 
recurrence, and lung cancer was associated with in-
hospital mortality. The overall in-hospital mortality rate 
was 11.3%. In a study done by Fidan A et al;[10] 79 were 
men and 29 were women, and the mean age was 51.74 +/- 
17.51. In 77 of the cases it was the first attack, while in 31 
it was recurrent. According to the severity of hemoptysis, 
it was classified as "mild" (<30 cm
3
), "moderate" (30-100 
cm
3
), "severe" (100-600 cm3) and "massive" (>600 cm
3
). 
Lung cancer was the leading cause of hemoptysis (34.3%) 
followed by bronchiectasis (25.0%), tuberculosis (17.6%), 
pneumonia (10.2%) and pulmonary embolism (4.6%). 
Statistical analysis by chi-square test revealed that most of 
the lung cancer patients had mild hemoptysis (odds ratio 
3.5; P<0.05), and the most frequent etiology in recurrent 
hemoptysis was bronchiectasis (odds ratio 3.25; P=0.01). 
Most of the lung cancer patients were male (P=0.002). 
 
Conclusion 
 
There is an increased possibility of a second episode 
of hemoptysis in patients with bacterial colonization of 
the respiratory tract or an initial episode of hemoptysis 
of unknown etiology. 
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